Saigal S, Sharma JP, Dhurwe R, Kumar S, Gurjar M (2015) Targeted temperature management: current evidence and practices in critical care
All three FDA-approved injection sitesabdomen, outer thigh, and upper armare equally effective
2016A030313749), and the Industry Technology and Development Special Fund Project of Guangdong Province (2013B021100017)
Each individual has unique needs, and this facility recognizes that one-size-fits-all solutions do not work
43 Although causative effect has not been established, DPP-4 inhibitor therapy should be discontinued immediately if a patient presents with signs of pancreatitis, such as severe abdominal pain, nausea, vomiting, and weight loss
4a and 4b), which were confirmed through immunofluorescence analysis of C11 BODIPY 581/591 and 4-HNE